Given the rising rates of obesity and diabetes, semaglutide could be used effectively to reduce the burden of these chronic diseases.

The New Innovator awards support investigators in the early stages of their careers.

The Alabama Maternal Health Task Force will lead state entities, community members and maternal health experts in developing and implementing a strategic plan aimed at reducing maternal mortality and morbidity across the state.

The growing dependence on technology, coupled with the increasing threat of intrusion and cyberattacks, requires greater security in the online world.

The UAB Marnix E. Heersink School of Medicine leadership team outlined key research focus areas to ensure continued growth over the next five to seven years.

Knockout of TXNIP improves diabetes-associated hyperglycemia and hyperglucagonemia.

Published results suggest the COVID-19 pandemic exacerbated the slow increase in pediatric Type 2 diabetes.

AHA recognizes the UAB Cardiovascular Institute’s dedication to ensuring all heart failure patients have access to best practices and lifesaving care.

The clinic — supported by a $3.4 million state appropriation — is part of the UAB School of Dentistry’s innovative efforts to combat the shortage of dentists in rural areas of the state.

UAB’s new director of the Division of Urogynecology discusses pelvic organ prolapse prevention, treatment and the importance of open conversations around the condition that affects many women in the United States.

A transformative gift to UAB from J. Frank Barefield, Jr. will help shape a more prosperous future for Birmingham and beyond.

The University of Alabama System approves plan to move forward with replacing Cooper Green’s current facility with a state-of-the-art medical clinic.

The clinically approved drug ruxolitinib suppressed a mouse model of melanoma that is resistant to immune checkpoint blockers.

Injury and illness can happen to anyone. Going to the right place of care could save lives.  

The ability to understand and acquire knowledge can be protected by following a healthy diet, regular exercise, vitamin D consumption and participating in social activities.

The funding from Alabama Innovation Corporation will help UAB startups make a profound impact in the biotechnology industry.

The Zorro-Flow Inc. is the newest startup from the UAB Harbert Institute for Innovation and Entrepreneurship. The device is the first external catheter to collect urine effectively, safely and comfortably from critically ill female neonates and children.

Everyone will experience aging, but can a person enhance their aging through simple modifications? UAB experts say yes.

The UAB projects will investigate was to improve and increase the use of artificial intelligence in biomedical research.

The study, an exception from informed consent trial, will compare whole blood to blood components in the treatment of traumatic injuries.